ATTENTION ESSA Pharma Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. for potential violations of federal securities laws. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.
November 17, 2024 | 1:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is under investigation by Levi & Korsinsky for potential securities law violations after halting a Phase 2 trial for a prostate cancer treatment.
The investigation by Levi & Korsinsky into potential securities law violations is likely to negatively impact investor sentiment and the stock price of ESSA Pharma Inc. in the short term. The halting of a Phase 2 trial can be seen as a setback in their product development, further contributing to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100